tiprankstipranks
BioNTech SE (DE:22UA)
XETRA:22UA
Holding DE:22UA?
Track your performance easily

BioNTech SE (22UA) Financial Statements

32 Followers

BioNTech SE Financial Overview

BioNTech SE's market cap is currently ―. The company's EPS TTM is €-1.955; its P/E ratio is -55.69; BioNTech SE is scheduled to report earnings on March 10, 2025, and the estimated EPS forecast is €0.48. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue---€ 3.20B€ 6.37B
Gross Profit---€ 2.03B€ 4.79B
EBIT---€ 2.33B€ 5.02B
EBITDA---€ 2.36B€ 5.05B
Net Income Common Stockholders---€ 1.67B€ 3.70B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 16.55B€ 13.88B€ 0.00€ 9.33B€ 6.17B
Total Assets€ 23.01B€ 23.28B-€ 21.16B€ 20.30B
Total Debt€ 219.10M€ 212.20M€ 0.00€ 238.90M€ 186.00M
Net Debt€ -16.33B€ -13.66B€ 0.00€ -9.10B€ -5.98B
Total Liabilities€ 2.76B€ 3.22B-€ 4.32B€ 4.39B
Stockholders Equity€ 20.25B€ 20.06B€ 0.00€ 16.83B€ 15.91B
Cash Flow-
Free Cash Flow---€ 3.84B€ 3.99B
Operating Cash Flow---€ 3.92B€ 4.05B
Investing Cash Flow---€ -78.40M€ 287.40M
Financing Cash Flow---€ -781.50M€ 80.30M
Currency in EUR

BioNTech SE Earnings and Revenue History

BioNTech SE Debt to Assets

BioNTech SE Cash Flow

BioNTech SE Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis